Previous research on the risk of UTIs with SGLT-2 inhibitor use has yielded conflicting results. Researchers conducted a population-based cohort study to explore this further.
Because many adults with diabetes are undiagnosed, researchers sought to examine the effects of routine outpatient random plasma glucose testing on rates of diabetes diagnosis in a retrospective cohort...
While statins are one of the most widely prescribed medications worldwide, concerns about the drugs’ associations with dysglycemia and new-onset diabetes still remain.
While previous studies have suggested that lower blood 25-hydroxyvitamin D levels are associated with the risk of type 2 diabetes, whether supplementation could affect this association is still unknown. ...
In a new study, CDC scientists evaluated trends in the incidence and prevalence of diagnosed type 1 and type 2 diabetes from 1980 to 2017. Some findings were encouraging, while others highlight areas of...
Because of the common nature of non-alcoholic fatty liver disease and the chance of progression to non-alcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma, researchers sought to estimate the...
Previous research has indicated that use of sodium-glucose cotransporter-2 inhibitors could be associated with a rare urologic necrotizing infection. In a recent analysis, the FDA sought to further examine...
While metformin is the most common treatment of choice in children with type 2 diabetes, early loss of glycemic control has been observed with metformin monotherapy.
Although type 2 diabetes is the leading cause of kidney failure, few long-term treatment options for renoprotection in these patients are currently available.
